MiCo BioMed Co Ltd
KOSDAQ:214610
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
My EG Services Bhd
KLSE:MYEG
|
MY |
|
Getinge AB
STO:GETI B
|
SE |
MiCo BioMed Co Ltd
Other Current Liabilities
MiCo BioMed Co Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
Other Current Liabilities
₩4.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Other Current Liabilities
₩35.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Other Current Liabilities
₩43.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Other Current Liabilities
₩19.5B
|
CAGR 3-Years
1 767%
|
CAGR 5-Years
528%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Other Current Liabilities
₩6.7B
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Other Current Liabilities
₩1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MiCo BioMed Co Ltd
Glance View
MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-06-22. The firm operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostics, anemia meters, blood glucose meters, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits.
See Also
What is MiCo BioMed Co Ltd's Other Current Liabilities?
Other Current Liabilities
4.1B
KRW
Based on the financial report for Dec 31, 2024, MiCo BioMed Co Ltd's Other Current Liabilities amounts to 4.1B KRW.
What is MiCo BioMed Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
32%
Over the last year, the Other Current Liabilities growth was -44%. The average annual Other Current Liabilities growth rates for MiCo BioMed Co Ltd have been 19% over the past three years , 26% over the past five years , and 32% over the past ten years .
